SPECIAL OFFER : 25% Super Discount For All !
Global Drugs for Vulvovaginal Candidiasis (VVC) Market Size, By Formulation Type (Topical (Cream, Lotion, Gel, Ointment, Aerosol, Foam, Powder, Solution etc.), Pessary (Suppositories, Kit), and Oral (Tablet, Capsule, Powder for Suspension etc.)), By Drug Types (Miconazole, Clotrimazole, Fluconazole, Econazole, and Others (Itraconazole, Nystatin, Tioconazole, amphotericin B Etc.)), and By End User (Hospital, Clinic, and Pharmacy), and By Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America); Trend Analysis, Competitive Market Share & Forecast, 2016-26
- Published Date: February 2020
- Report ID: BWC19400
- Available Format: PDF
- Page: 180
1. Research Framework
1.1. Research
Objective
1.2. Product
Overview
1.3. Market
Segmentation
2. Research Methodology
2.1. Qualitative
Research
2.1.1.
Primary & Secondary Sources
2.2. Quantitative
Research
2.2.1.
Primary & Secondary Sources
2.3. Breakdown
of Primary Research Respondents, By Region
2.3.1.
Secondary Research
2.3.2.
Primary Research
2.4. Breakdown
of Primary Research Respondents
2.5. Market
Size Estimation
2.6. Assumption
for the Study
2.7. Market
Breakdown & Data Triangulation
3. Global Drugs for Vulvovaginal
Candidiasis (VVC) Market Industry Insights
3.1. DROC
Analysis
3.1.1.
Growth Drivers
3.1.2.
Restraints
3.1.3.
Opportunities
3.1.4.
Challenges
3.2. Technological
Landscape
3.3. Regulatory
Framework
3.4. Company
market share analysis, 2019
3.5. Porter’s
Five forces analysis
3.5.1.
Bargaining Power of Suppliers
3.5.2.
Bargaining Power of Buyers
3.5.3.
Threat of New Entrants
3.5.4.
Threat of Substitutes
3.5.5.
Intensity of Rivalry
4. Global Drugs for Vulvovaginal
Candidiasis (VVC) Market Overview
4.1. Market
Size & Forecast 2016-2026
4.1.1.
By Value (USD)
4.2. Market
Share & Forecast
4.2.1.
By Formulation Type
4.2.1.1.
Topical (Cream, Lotion, Gel, Ointment,
Aerosol, Foam, Powder, Solution etc.)
4.2.1.2.
Pessary (Suppositories, Kit)
4.2.1.3.
Oral (Tablet, Capsule, Powder for Suspension
etc.)
4.2.2.
By Drug Type
4.2.2.1.
Miconazole
4.2.2.2.
Clotrimazole
4.2.2.3.
Fluconazole
4.2.2.4.
Econazole
4.2.2.5.
Others (Itraconazole, Nystatin, Tioconazole,
amphotericin B Etc.)
4.2.3.
By End User
4.2.3.1.
Hospital
4.2.3.2.
Clinic
4.2.3.3.
Pharmacy
4.2.4.
By Region
4.2.4.1.
North America
4.2.4.2.
Europe
4.2.4.3.
Asia Pacific
4.2.4.4.
Latin America
4.2.4.5.
Middle East & Africa
5. North America Drugs for Vulvovaginal
Candidiasis (VVC) Market
5.1. Market
estimates & forecast
5.1.1.
By Formulation Type
5.1.2.
By Drug Type
5.1.3.
By End user
5.1.4.
By Country
5.1.4.1.
U.S
5.1.4.2.
Canada
6. Europe Drugs for Vulvovaginal
Candidiasis (VVC) Market
6.1. Market
estimates & forecast
6.1.1.
By Formulation Type
6.1.2.
By Drug Type
6.1.3.
By End user
6.1.4.
By Country
6.1.4.1.
Germany
6.1.4.2.
U.K
6.1.4.3.
France
6.1.4.4.
Italy
6.1.4.5.
Rest of Europe
7. Asia Pacific Drugs for Vulvovaginal
Candidiasis (VVC) Market
7.1. Market
estimates & forecast
7.1.1.
By Formulation Type
7.1.2.
By Drug Type
7.1.3.
By End user
7.1.4.
By Country
7.1.4.1.
China
7.1.4.2.
India
7.1.4.3.
Japan
7.1.4.4.
Rest of APAC
8. Latin America Drugs for Vulvovaginal
Candidiasis (VVC) Market
8.1. Market
estimates & forecast
8.1.1.
By Formulation Type
8.1.2.
By Drug Type
8.1.3.
By End user
8.1.4.
By Country
8.1.4.1.
Brazil
8.1.4.2.
Argentina
8.1.4.3.
Rest of Latin America
9. Middle East & Africa Drugs for
Vulvovaginal Candidiasis (VVC) Market
9.1. Market
estimates & forecast
9.1.1.
By Formulation Type
9.1.2.
By Drug Type
9.1.3.
By End user
9.1.4.
By Country
9.1.4.1.
Saudi Arabia
9.1.4.2.
UAE
9.1.4.3.
South Africa
9.1.4.4.
Rest of MEA
10.Company Profile (Company Overview,
Financial Matrix, Key Product landscape, Key Personnel, Key Competitors,
Contact Address, and Strategic Outlook) *
10.1.
Bayer
10.2.
Perrigo
10.3.
J & J
10.4.
Pfizer
10.5.
Bristol-Myers Squibb
10.6.
Effik
10.7.
Teva
10.8.
Sanofi
10.9.
Cisen Pharmaceutical
10.10.
Kingyork Group
10.11.
Janssen
10.12.
Actavis
10.13.
Tianjin Kingyork Group
10.14.
Tianjin Pacific Pharmaceutical
10.15.
Lunan Pharmaceutical
10.16.
Viamet Pharmaceuticals
10.17.
Other Prominent Players
* Financial information of
non-listed Companies will be provided as per availability
**The segmentation and the
companies are subjected to modifications based on in-depth secondary for the
final deliverable
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.